Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children

NCT: NCT05378581 · COMPLETED

NCT IDNCT05378581
StatusCOMPLETED
Start Date2022-09-23
Completion2026-04-30

Brief Summary

Main objective : Evaluate the effect of using a virtual reality mask during the blood test and pricks tests in allergic children aged from 7 to 13 years. Hypothesis : Using virtual reality mask during blood test and pricks tests for allergic kids from 7 to 13 would reduce anxiety and pain

Frequently Asked Questions

What is Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children?

Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children is a clinical trial registered under NCT05378581. Current status: COMPLETED.

What is the status of NCT05378581?

The current status of NCT05378581 (Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children) is: COMPLETED.

When did Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children start?

Use of Virtual Reality Mask During Blood and Skin Allergic Tests in 7 to 13 Children started on 2022-09-23.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑